poisar

Stocks · News reference

UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28

BenzingaAug 6, 2026, 6:43 PMBenzinga Newsdesk

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 6, 2026, 6:43 PM
Checked
Aug 6, 2026, 6:43 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading